178 related articles for article (PubMed ID: 8344351)
1. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6.
Oldenburg HS; Rogy MA; Lazarus DD; Van Zee KJ; Keeler BP; Chizzonite RA; Lowry SF; Moldawer LL
Eur J Immunol; 1993 Aug; 23(8):1889-94. PubMed ID: 8344351
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response.
Oldenburg HS; Pruitt JH; Lazarus DD; Rogy MA; Chizzonite R; Lowry SF; Moldawer LL
Cytokine; 1995 Aug; 7(6):510-6. PubMed ID: 8580366
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis.
Kaibara A; Espat NJ; Auffenberg T; Abouhamze AS; Martin D; Kalra S; Moldawer LL
Cytokine; 1998 Jun; 10(6):452-6. PubMed ID: 9632532
[TBL] [Abstract][Full Text] [Related]
5. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E
Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 receptor blockade attenuates the host inflammatory response.
Gershenwald JE; Fong YM; Fahey TJ; Calvano SE; Chizzonite R; Kilian PL; Lowry SF; Moldawer LL
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):4966-70. PubMed ID: 1695006
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
Yasumoto K; Mukaida N; Harada A; Kuno K; Akiyama M; Nakashima E; Fujioka N; Mai M; Kasahara T; Fujimoto-Ouchi K
Cancer Res; 1995 Feb; 55(4):921-7. PubMed ID: 7850809
[TBL] [Abstract][Full Text] [Related]
8. Induction of an acute phase response in rats stimulates the expression of alpha 1(I) procollagen messenger ribonucleic acid in their livers. Possible role of interleukin-6.
Greenwel P; Iraburu MJ; Reyes-Romero M; Meraz-Cruz N; Casado E; Solis-Herruzo JA; Rojkind M
Lab Invest; 1995 Jan; 72(1):83-91. PubMed ID: 7837795
[TBL] [Abstract][Full Text] [Related]
9. Hepatic gene expression and cytokine responses to sterile inflammation: comparison with cecal ligation and puncture sepsis in the rat.
Bazel S; Andrejko KM; Chen J; Deutschman CS
Shock; 1999 May; 11(5):347-55. PubMed ID: 10353541
[TBL] [Abstract][Full Text] [Related]
10. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis.
Brito BE; O'Rourke LM; Pan Y; Anglin J; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2583-9. PubMed ID: 10509653
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 regulates hepatic transporters during acute-phase response.
Siewert E; Dietrich CG; Lammert F; Heinrich PC; Matern S; Gartung C; Geier A
Biochem Biophys Res Commun; 2004 Sep; 322(1):232-8. PubMed ID: 15313196
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
[TBL] [Abstract][Full Text] [Related]
13. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice.
Labow M; Shuster D; Zetterstrom M; Nunes P; Terry R; Cullinan EB; Bartfai T; Solorzano C; Moldawer LL; Chizzonite R; McIntyre KW
J Immunol; 1997 Sep; 159(5):2452-61. PubMed ID: 9278338
[TBL] [Abstract][Full Text] [Related]
14. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice.
Fantuzzi G; Ku G; Harding MW; Livingston DJ; Sipe JD; Kuida K; Flavell RA; Dinarello CA
J Immunol; 1997 Feb; 158(4):1818-24. PubMed ID: 9029121
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra.
Josephs MD; Solorzano CC; Taylor M; Rosenberg JJ; Topping D; Abouhamze A; Mackay SL; Hirsch E; Hirsh D; Labow M; Moldawer LL
Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R824-30. PubMed ID: 10749768
[TBL] [Abstract][Full Text] [Related]
16. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
17. Acute phase response impairs host defense against Pseudomonas aeruginosa pneumonia in mice.
Renckens R; van Westerloo DJ; Roelofs JJ; Pater JM; Schultz MJ; Florquin S; van der Poll T
Crit Care Med; 2008 Feb; 36(2):580-7. PubMed ID: 18091542
[TBL] [Abstract][Full Text] [Related]
18. Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation.
Calpe-Berdiel L; Escolà-Gil JC; Benítez S; Bancells C; González-Sastre F; Palomer X; Blanco-Vaca F
Life Sci; 2007 May; 80(21):1951-6. PubMed ID: 17382351
[TBL] [Abstract][Full Text] [Related]
19. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.
Siewert E; Bort R; Kluge R; Heinrich PC; Castell J; Jover R
Hepatology; 2000 Jul; 32(1):49-55. PubMed ID: 10869288
[TBL] [Abstract][Full Text] [Related]
20. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
